The invention relates to a pharmaceutical product intended to be employed in dermatology. According to the invention, the product is based on hydrophilic macromolecular compounds of the polyacrylic derivative type containing 0.01...10% associations of cobalt and copper complexes with oxicams as non-steroid anti-inflammatory agents, 1...5% non-ionic surface-active agents, 1...10% lipophilic absorption promoters and 5...20% volatile alcoholic components.Invenţia se referă la un produs farmaceutic, utilizat în dermatologie. Produsul conform invenţiei este pe bază de compuşi macromoleculari, hidrofili, de tip derivaţi poliacrilici, conţinând 0,01...10% asocieri de complecşi ai cobaltului şi cuprului cu oxicami ca agenţi antiinflamatori nesteroidieni, 1...5% agenţi tensioactivi neionici, 1...10% promotori de absorbţie lipofili şi 5...20% componente alcoolice volatile.
